openPR Logo
Press release

Global OTC Consumer Health Products Market Size Estimated to Cross USD 261.98 Billion By 2030, Growing at a CAGR of 4.0% | Infinium Global Research

12-06-2023 02:24 PM CET | Health & Medicine

Press release from: Infinium Global Research LLP

Global OTC Consumer Health Products Market Size Estimated

Infinium Global Research, a leading market intelligence company, recently released an exhaustive report on the OTC Consumer Health Products Market, offering a profound understanding of its global and regional landscape, highlighting key drivers, constraints, and future trends.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/60

Market Insight:

The global OTC consumer health products market, valued at USD 191.9 billion in 2022, is projected to ascend to USD 261.98 billion by 2030, exhibiting a steady CAGR of 4.00% during the forecast period 2023-2030. This market encompasses a spectrum of healthcare solutions directly accessible to consumers without prescription requirements. Ranging from medications to wellness products, supplements, and personal care items, OTC products address various health needs. Convenience, rising health awareness, and self-care inclinations are driving factors fostering market growth. Innovations, marketing strategies, and regulatory shifts continue to mold this sector to meet evolving consumer preferences and healthcare trends.

Market Dynamics:

The expansion of the population, coupled with increasing health consciousness, is fueling the demand for OTC health products. Consumers, aware of lifestyle-related ailments, are embracing self-medication practices due to rising healthcare costs, propelling the market forward. However, potential adverse effects of unsupervised self-medication pose challenges despite the surge in e-commerce facilitating online medication purchases.

Regional Insights:

North America is anticipated to lead the market, attributing its position to strong consumer purchasing power and high disposable income. The United States and Canada spearhead OTC consumer health product adoption within this region. In Europe, heightened awareness of lifestyle diseases bolsters market growth, while the Asia Pacific emerges as the fastest-growing region. Increasing consumer health concerns and enhanced product accessibility in pharmaceutical and retail spaces underpin this growth trajectory.

Segmentation:

The report covers key segments including skin care, nutritional supplements, oral care, wound care management, gastrointestinal products, and distribution channels such as hospital and independent pharmacies, departmental stores, and online platforms.

Featured Companies:

Profiles of major market players like Sanofi, Johnson & Johnson, Bayer AG, and others are featured, offering comprehensive insights into their contributions and strategies within the OTC consumer health products market.

The Infinium Global Research report on the OTC consumer health products market provides an in-depth understanding of this burgeoning industry, equipping stakeholders with essential information to navigate the evolving market landscape.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/60

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. OTC Consumer Health Products Market Highlights

2.2. OTC Consumer Health Products Market Projection

2.3. OTC Consumer Health Products Market Regional Highlights

Chapter 3. Global OTC Consumer Health Products Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter`s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Type

3.4.2. IGR-Growth Matrix Analysis by Distribution Channel

3.4.3. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of OTC Consumer Health Products Market

Chapter 4. OTC Consumer Health Products Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global OTC Consumer Health Products Market

5.2. Companies Profiles

5.2.1. Sanofi

5.2.2. Johnson & Johnson, Inc.

5.2.3. Bayer AG

5.2.4. GLENMARK PHARMACEUTICALS LTD.

5.2.5. Piramal Enterprises Ltd.

5.2.6. GSK plc.

5.2.7. Sun Pharmaceutical Industries Ltd.

5.2.8. Abbott Laboratories

5.2.9. Zeria Pharmaceutical Co., Ltd.

5.2.10. Teva Pharmaceutical Industries Ltd.

Chapter 6. Global OTC Consumer Health Products Market by Type

6.1. Skin Care Products

6.2. Nutritional Supplements

6.3. Oral Care Products

6.4. Wound Care Management Products

6.5. Gastrointestinal Products

6.6. Others

Chapter 7. Global OTC Consumer Health Products Market by Distribution Channel

7.1. Hospital Pharmacy

7.2. Independent Pharmacies

7.3. Departmental Stores

7.4. Online

Chapter 8. Global OTC Consumer Health Products Market by Region 2023-2030

8.1. North America

8.1.1. North America OTC Consumer Health Products Market by Type

8.1.2. North America OTC Consumer Health Products Market by Distribution Channel

8.1.3. North America OTC Consumer Health Products Market by Country

8.1.3.1. The U.S. OTC Consumer Health Products Market

8.1.3.1.1. The U.S. OTC Consumer Health Products Market by Type

8.1.3.1.2. The U.S. OTC Consumer Health Products Market by Distribution Channel

8.1.3.2. Canada OTC Consumer Health Products Market

8.1.3.2.1. Canada OTC Consumer Health Products Market by Type

8.1.3.2.2. Canada OTC Consumer Health Products Market by Distribution Channel

8.1.3.3. Mexico OTC Consumer Health Products Market

8.1.3.3.1. Mexico OTC Consumer Health Products Market by Type

8.1.3.3.2. Mexico OTC Consumer Health Products Market by Distribution Channel

8.2. Europe

8.2.1. Europe OTC Consumer Health Products Market by Type

8.2.2. Europe OTC Consumer Health Products Market by Distribution Channel

8.2.3. Europe OTC Consumer Health Products Market by Country

8.2.3.1. Germany OTC Consumer Health Products Market

8.2.3.1.1. Germany OTC Consumer Health Products Market by Type

8.2.3.1.2. Germany OTC Consumer Health Products Market by Distribution Channel

8.2.3.2. United Kingdom OTC Consumer Health Products Market

8.2.3.2.1. United Kingdom OTC Consumer Health Products Market by Type

8.2.3.2.2. United Kingdom OTC Consumer Health Products Market by Distribution Channel

8.2.3.3. France OTC Consumer Health Products Market

8.2.3.3.1. France OTC Consumer Health Products Market by Type

8.2.3.3.2. France OTC Consumer Health Products Market by Distribution Channel

8.2.3.4. Italy OTC Consumer Health Products Market

8.2.3.4.1. Italy OTC Consumer Health Products Market by Type

8.2.3.4.2. Italy OTC Consumer Health Products Market by Distribution Channel

8.2.3.5. Rest of Europe OTC Consumer Health Products Market

8.2.3.5.1. Rest of Europe OTC Consumer Health Products Market by Type

8.2.3.5.2. Rest of Europe OTC Consumer Health Products Market by Distribution Channel

8.3. Asia Pacific

8.3.1. Asia Pacific OTC Consumer Health Products Market by Type

8.3.2. Asia Pacific OTC Consumer Health Products Market by Distribution Channel

8.3.3. Asia Pacific OTC Consumer Health Products Market by Country

8.3.3.1. China OTC Consumer Health Products Market

8.3.3.1.1. China OTC Consumer Health Products Market by Type

8.3.3.1.2. China OTC Consumer Health Products Market by Distribution Channel

8.3.3.2. Japan OTC Consumer Health Products Market

8.3.3.2.1. Japan OTC Consumer Health Products Market by Type

8.3.3.2.2. Japan OTC Consumer Health Products Market by Distribution Channel

8.3.3.3. India OTC Consumer Health Products Market

8.3.3.3.1. India OTC Consumer Health Products Market by Type

8.3.3.3.2. India OTC Consumer Health Products Market by Distribution Channel

8.3.3.4. South Korea OTC Consumer Health Products Market

8.3.3.4.1. South Korea OTC Consumer Health Products Market by Type

8.3.3.4.2. South Korea OTC Consumer Health Products Market by Distribution Channel

8.3.3.5. Australia OTC Consumer Health Products Market

8.3.3.5.1. Australia OTC Consumer Health Products Market by Type

8.3.3.5.2. Australia OTC Consumer Health Products Market by Distribution Channel

8.3.3.6. Rest of Asia-Pacific OTC Consumer Health Products Market

8.3.3.6.1. Rest of Asia-Pacific OTC Consumer Health Products Market by Type

8.3.3.6.2. Rest of Asia-Pacific OTC Consumer Health Products Market by Distribution Channel

8.4. RoW

8.4.1. RoW OTC Consumer Health Products Market by Type

8.4.2. RoW OTC Consumer Health Products Market by Distribution Channel

8.4.3. RoW OTC Consumer Health Products Market by Sub-region

8.4.3.1. Latin America OTC Consumer Health Products Market

8.4.3.1.1. Latin America OTC Consumer Health Products Market by Type

8.4.3.1.2. Latin America OTC Consumer Health Products Market by Distribution Channel

8.4.3.2. Middle East OTC Consumer Health Products Market

8.4.3.2.1. Middle East OTC Consumer Health Products Market by Type

8.4.3.2.2. Middle East OTC Consumer Health Products Market by Distribution Channel

8.4.3.3. Africa OTC Consumer Health Products Market

8.4.3.3.1. Africa OTC Consumer Health Products Market by Type

8.4.3.3.2. Africa OTC Consumer Health Products Market by Distribution Channel

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/60

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of OTC consumer health products.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global OTC Consumer Health Products Market Size Estimated to Cross USD 261.98 Billion By 2030, Growing at a CAGR of 4.0% | Infinium Global Research here

News-ID: 3317943 • Views:

More Releases from Infinium Global Research LLP

Global Sterilization Services Market Size Worth USD 12.55 Billion By 2030 | CAGR 7.24%: Infinium Global Research
Global Sterilization Services Market Size Worth USD 12.55 Billion By 2030 | CAGR …
Infinium Global Research, a leading provider of market intelligence, has recently launched an in-depth report on the Global Sterilization Services Market, offering comprehensive analysis and detailed insights into its segments and market trends. The comprehensive study explores the impact of various factors such as drivers, restraints, and macro indicators on both the global and regional sterilization services market, providing crucial forecasts and dollar value projections. To Know More Request a Sample of
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surpass USD 5.09 Billion By the End of 2030 with a Growing CAGR of 9.56% | Infinium Global Research
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surp …
Infinium Global Research introduces a detailed analysis of the global and regional Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) market, providing an extensive study of its segments, trends, forecasts, and dollar values in their latest report. This comprehensive study empowers stakeholders in the pharmaceutical and healthcare sectors with invaluable insights into this burgeoning market. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/420 Market Insight: The global Proprotein Convertase Subtilisin/Kexin Type 9 market,
Global Neuromodulation Market is Anticipated to Reach USD 7.27 Billion and Growing at a CAGR of 9.59% During Forecast Period 2023 - 2030 | IGR
Global Neuromodulation Market is Anticipated to Reach USD 7.27 Billion and Growi …
Infinium Global Research, a pioneering market intelligence firm, introduces a comprehensive report delving into the Global Neuromodulation Market, providing extensive analysis and in-depth exploration of its segments, market trends, and projections. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/93 Market Insight: The global neuromodulation market, valued at USD 3.51 Billion in 2022, is poised to ascend to USD 7.27 Billion by 2030, exhibiting a noteworthy CAGR of 9.59% during the forecast
Global Botulinum Toxin Market Growing at a CAGR of 9.12% to Reach USD 20.09 Billion By 2030 | Infinium Global Research
Global Botulinum Toxin Market Growing at a CAGR of 9.12% to Reach USD 20.09 Bill …
Infinium Global Research, a leading market intelligence firm, has released an extensive report delving into the dynamics and trends shaping the Global Botulinum Toxin Market. This comprehensive analysis spans both the global landscape and regional perspectives, providing invaluable insights into the market's trajectory, influencing factors, and growth projections. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/89 Market Insight: The global botulinum toxin market, valued at USD 10.02 billion in 2022, is

All 5 Releases


More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current